PET/MRI与多参数MRI诊断原发性前列腺癌的比较:一项Meta分析
本Meta分析纳入9项研究共353例患者,在同一患者队列中比较PET/MRI与多参数MRI诊断原发性前列腺癌的效能。PET/MRI汇总敏感度0.783、特异度0.899,多参数MRI敏感度0.603、特异度0.887;PET/MRI的AUC高于多参数MRI(0.9311 vs 0.8403,P=0.0036)。作者认为PET/MRI诊断效能很好,优于多参数MRI。
要点
- PET/MRI诊断原发性前列腺癌的汇总敏感度0.783、特异度0.899。
- 多参数MRI汇总敏感度0.603、特异度0.887,AUC低于PET/MRI。
- 异质性主要潜在原因是以区域为基础而非以病灶为基础的分析。
核心结论
- PET/MRI对原发性前列腺癌诊断效能很好,优于多参数MRI。
研究设计与样本
- 系统检索截至2019年1月的文献,纳入9项在同一患者队列中评估PET/MRI与多参数MRI诊断原发性前列腺癌的研究,共353例患者。
- 纳入研究需有足够数据构建真阳性、假阳性、假阴性、真阴性的2×2列联表,并用诊断准确性研究质量评估工具第2版评价质量。
- 汇总敏感度、特异度,采用汇总受试者工作特征曲线及曲线下面积比较PET/MRI与多参数MRI的效能。
诊断标准与关键数值
- PET/MRI汇总敏感度0.783(95%CI 0.758-0.807),汇总特异度0.899(95%CI 0.879-0.917)。
- 多参数MRI汇总敏感度0.603(95%CI 0.574-0.631),汇总特异度0.887(95%CI 0.866-0.906)。
- PET/MRI的AUC为0.9311(95%CI 0.8990-0.9632),多参数MRI的AUC为0.8403(95%CI 0.7864-0.8942),PET/MRI较高(P=0.0036)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 结局存在中等程度异质性,Meta回归分析显示主要潜在原因是以区域为基础而非以病灶为基础的分析。
- 原文未报告发表偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: This meta-analysis aimed to compare the diagnostic performance of positron emission tomography (PET)/MRI using various radiotracers with multiparametric (mp) MRI for detection of primary prostate cancer (PCa).
METHODS: A systematic literature search up to January 2019 was performed to identify studies that evaluated the diagnostic value of PET/MRI and mpMRI for detection of PCa in the same patient cohorts and had sufficient data to construct 2 × 2 contingency tables for true-positive (TP), false-positive (FP), false-negative (FN), and true-negative (TN) results. The quality of each study was assessed using the Quality Assessment of Diagnostic Accuracy Studies-2 tool, and pooled sensitivity (SEN) and specificity (SPE) were calculated. Summary receiver operating characteristic (ROC) curves and area under the curves (AUCs) were used to compare the performances of PET/MRI and mpMRI.
RESULTS: We identified 9 eligible studies that included a total of 353 patients. PET/MRI had a SEN of 0.783 (95% CI, 0.758-0.807) and a SPE of 0.899 (95% CI, 0.879-0.917), and mpMRI had a SEN of 0.603 (95% CI, 0.574-0.631) and a SPE of 0.887 (95% CI, 0.866-0.906). PET/MRI had a higher AUC than mpMRI (0.9311, 95% CI, 0.8990-0.9632 vs. 0.8403, 95% CI, 0.7864-0.8942; P = 0.0036). There was no notable publication bias, but there was medium heterogeneity in outcomes. The meta-regression analysis showed the major potential cause of heterogeneity was the use of region-based rather than lesion-based analysis.
CONCLUSION: PET/MRI has very good diagnostic performance and outperforms mpMRI for the diagnosis of primary PCa.
引用
- Li M, Huang Z, Yu H, et al. Comparison of PET/MRI with multiparametric MRI in diagnosis of primary prostate cancer: A meta-analysis. Eur J Radiol. 2019. PMID: 30927951. doi:10.1016/j.ejrad.2019.02.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。